Wellness HealthCare logo Wellness HealthCare
Contact

Three Focus Areas

Our three focus areas

Each area began at a gap in the market, and they're at different stages. Where collaboration fits is marked.

Flagship
01
2026 Q3 Beta Launch

Pet Healthcare
Pet Diabetes & Weight Management + Pet CGM App

A pet healthcare line combining a Pet CGM (continuous glucose monitor), Pet CGM App (mobile app for guardians), and Pet Premium Glucose Solution. The Pet CGM App is preparing for a 2026 Q3 Beta launch, and we're piloting with veterinary clinics, pet food OEM, and pet insurance partners.

Market Context

15MPet-owning households (KR)
30%+Companion-animal obesity
20%/yrPet healthcare market growth

Metabolic diseases — diabetes, pancreatitis, kidney disease — are rising rapidly. Yet daily blood draws for pets aren't realistic.

Our Solution

An integrated pet healthcare lineup with three axes.

  • Pet CGM — Continuous glucose monitor
  • Pet CGM App — Mobile app for guardians (★ 2026 Q3 launch)
  • Pet Premium Glucose Solution — Medical food for companion animals
  • Veterinarian Dashboard — Multi-patient management
  • Pet Insurance Integration — Data-driven personalized plans

Pet CGM App · Coming Soon

Your pet's glucose, from a new perspective

Not just numbers — a next-gen Pet CGM monitoring app designed for intuitive understanding by guardians.

Integrated Health Indicator An at-a-glance, easy-to-grasp display
Friendly Alert System Intuitive, approachable messages
Personalized Voice Guidance Familiar, comforting voice alerts
Intuitive Visual Feedback See state changes at a glance
🚀 2026 Q3 Beta launch planned · Now accepting pre-registrations Pre-register for Beta →

Target Customers

B2B · Veterinary Clinics B2B · Pet Food OEM B2B · Pet Insurance B2C · Pet Owners

Note · This solution and the Pet CGM App are not diagnostic or therapeutic medical devices — they are daily monitoring aids. Consult a veterinarian if your pet shows any sign of health concern.

02
R&D Phase

CKM
Continuous Ketone Monitoring

Ketone is a direct marker of fat metabolism. We're researching next-generation monitoring that combines vCGM infrastructure with a ketone prediction model — addressing both ketogenic dieters and Type 1 diabetes patients in one platform.

Why Ketone Matters

Ketones are a metabolic by-product of fat oxidation. They matter in two contexts.

  • Ketogenic diet — Confirms fat metabolism activity
  • Type 1 diabetes — Early signal of ketoacidosis (DKA)
  • Risk of diabetic ketoacidosis emergencies
  • Validation of low-carb diet results

R&D Approach

Leveraging vCGM's existing meal/exercise input infrastructure and 30-rep learning engine, we are validating a prediction model that combines breath, urine, and blood ketone data. Launch timing and certification scope will be determined by clinical validation results.

Target Customers

B2B · Medical Institutions B2B · Clinical CRO B2B · Ketone Device Manufacturers B2C · Ketogenic Dieters B2C · Type 1 Diabetes Patients

Important — Medical Disclaimer

CKM is currently in R&D phase and is not a regulator-approved medical device. This solution cannot replace the diagnosis or treatment of Type 1 diabetes ketoacidosis (DKA) and must not be used as a basis for medical decisions. If symptoms of ketoacidosis appear (severe thirst, rapid breathing, fruity-smelling breath, vomiting, altered consciousness), proceed to the emergency room immediately, and all treatment and medication decisions must be made through physician consultation.

03
B2B Pilot in Progress

vCGM B2B
Enterprise · Clinic SaaS

A B2B system that extends the core engine of the personal vCGM app into multi-user dashboards, admin reports, and APIs. Currently piloting with insurance, corporate healthcare, veterinary clinics, and CROs.

Why B2B

30 logsFor 1st personalization
No CGMZero device cost & logistics

Glucose management isn't a single-person problem. Family care, employer screening, clinical trials, insurance risk evaluation — more and more contexts demand simultaneous oversight of many users. If we can deliver the same insight without CGM device cost or logistics, we reach more people.

Core Features

  • No CGM required · meal/exercise input based
  • 30-rep learning Bayesian engine
  • Multi-user dashboards
  • Admin reports · API integration
  • Family plans · group challenges
  • White-label option

Target Customers

B2B · Insurance B2B · Corporate Healthcare B2B · Veterinary Clinics B2B · Clinical CRO B2C · Family Plan

Note · vCGM B2B System is not a medical device — it is a reference-only digital healthcare tool. Diagnostic and medication decisions must be made through physician consultation.

Customer Segments

Customer matrix at a glance

All three areas serve both B2B and B2C. Whichever channel a customer enters through, the underlying data connectivity remains.

Pet Healthcare

Pet Diabetes & Weight Management

B2B
Veterinary Clinics Pet Food OEM Pet Insurance
B2C
Pet Owners
CKM

Continuous Ketone Monitoring

B2B
Medical Institutions Clinical CRO Device Makers
B2C
Ketogenic Dieters Type 1 Diabetes
vCGM B2B

Enterprise · Clinic SaaS

B2B
Insurance Corporate Healthcare Veterinary Clinics CRO
B2C
Family Plan
How to Work Together

Four collaboration models

Pick the form that fits your area and stage — from light pilot trials to deep joint research.

🤝

OEM · Co-Brand

Co-developing products, apps, and content under a partner brand. Pet food, medical food, white-label SaaS.

🧪

Pilot Operations

Short-term trials with your customers, patients, or employees. 4–12 week reports provided.

🔬

R&D Joint Research

Clinical data analysis, prediction model validation, co-authored publications. Medical institutions and CROs welcome.

🌐

Distribution Partnership

Domestic channel onboarding or international (China, Southeast Asia, Middle East) market entry. Our site runs in KO · EN · ZH.

FAQ

Frequently asked questions

The four most common questions during partnership review.

📍 Where is each business area in its development stage?

Pet Healthcare is in Pilot phase with a few veterinary clinic and pet-food partners.

CKM is in R&D phase, validating its ketone prediction model and collecting clinical data — official launch timing and certification scope are to be determined.

vCGM B2B System is in Pilot phase with corporate healthcare and clinical partners.

🤝 What B2B collaboration models are available?

Four formats are available.

OEM — co-branded products, apps, and content
Pilot Operations — 4 to 12 week trial deployments with your customer base
R&D Joint Research — clinical, data analysis, and technical validation
Distribution Partnership — domestic channel entry or international markets (China, Southeast Asia, Middle East)

For details, contact us via the contact page or [email protected].

⚕️ Are these solutions medical devices?

No. All solutions introduced on this page are not regulator-approved medical devices — they are reference-only digital healthcare tools for daily management and lifestyle improvement.

In particular, CKM is in R&D phase and cannot replace the diagnosis or treatment of Type 1 diabetes ketoacidosis (DKA). All diagnostic, medication, and treatment decisions must be made in consultation with a physician or veterinarian.

🔁 How is the personal vCGM app different from the vCGM B2B System?

The personal vCGM app is a single-user product where one person logs meals and exercise and receives personalized blood-glucose prediction after 30 reps of learning.

The vCGM B2B System extends the same engine into multi-user dashboards, admin reports, and API integration — enabling corporate healthcare, clinics, veterinary clinics, and insurers to manage many customers simultaneously. Family plans, group challenges, and white-label options are also included.

Want to build with us?

Whether OEM, Pilot, R&D, or Distribution — tell us your area and stage, and we'll outline collaboration paths that fit.

Partnership Inquiry Send an Email